Eton Pharmaceuticals (ETON) Cash & Equivalents (2017 - 2026)
Eton Pharmaceuticals' Cash & Equivalents was $26.85 million in Q2 2026, up 5.8% from $25.38 million a year earlier.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Eton Pharmaceuticals came in at $25.94 million, up 73.7% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $14.94 million in FY2024 (-30.2%), $21.39 million in FY2023 (+31.2%), $16.31 million in FY2022 (+13.2%) and $14.41 million in FY2021 (-32.4%).
- Quarterly Cash & Equivalents has moved between $13.38 million (Q3 2022) and $37.12 million (Q3 2025) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last seven quarters, with growth averaging 24.6%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 209.7%); the worst was Q3 2022 (a decline of 41.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Eton Pharmaceuticals | 1.57 Bn | 1.45 Bn | 25.41 Mn | 26.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.85 Mn |
| Dec 31, 2025 | 25.94 Mn |
| Sep 30, 2025 | 37.12 Mn |
| Jun 30, 2025 | 25.38 Mn |
| Mar 31, 2025 | 17.42 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 20.26 Mn |
| Jun 30, 2024 | 17.69 Mn |
| Mar 31, 2024 | 16.66 Mn |
| Dec 31, 2023 | 21.39 Mn |
| Sep 30, 2023 | 22.07 Mn |
| Jun 30, 2023 | 21.57 Mn |
| Mar 31, 2023 | 14.71 Mn |
| Dec 31, 2022 | 16.31 Mn |
| Sep 30, 2022 | 13.38 Mn |
| Jun 30, 2022 | 17.05 Mn |
| Mar 31, 2022 | 15.23 Mn |
| Dec 31, 2021 | 14.41 Mn |
| Sep 30, 2021 | 22.71 Mn |
| Jun 30, 2021 | 25.80 Mn |
API Access
Eton Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();